REVB logo
REVB NASDAQ US

Revelation Biosciences, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2020
$1.25
▲ +$0.02 (+1.63%)
Vol 53K
3
Quality Score
fail
Mkt Cap
$4.7M
ROE
-145.0%
D/E
0.00
Beta
-0.12
52W
$1–$60

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

SBFM
Sunshine Biopharma Inc
$6.0M
AKTX
Akari Therapeutics PLC
$9.4M
FBLG
Fibrobiologics Inc
$15.0M
SILO
Silo Pharma Inc
$4.5M
VIVS
VivoSim Labs Inc
$4.7M
SHPH
Shuttle Pharmaceuticals Holdings Inc
$2.9M
MTVA
MetaVia Inc
$19.4M

Earnings

Beat rate: 25.0%
Next Report May 06, 2026
EPS Estimate: $-1.17
Quarter EPS Est EPS Act Surprise
Mar 2026 $-1.17 — —
Dec 2025 $-3.73 $-23.95 $-20.22
Sep 2025 $-5.45 $-7.08 $-1.63
Jun 2025 $-18.18 $-28.04 $-9.86

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -240.3% -505.4% -240.3% -240.3% -240.3% -145.0%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 3.42 3.61 3.42 3.42 3.42 6.92

Key Ratios

ROA (TTM)
-112.7%
P/B
0.8
EPS (TTM)
$-24.99
CF/Share
$0.23
52W High
$60.48
52W Low
$0.83
$0.83 52-Week Range $60.48

How does REVB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

REVB AAPG ABEO ABOS ABP

REVB valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.8
▼ 67% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

REVB profitability vs Biotechnology peers

ROE
-145.0%
▼ 116% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-112.7%
▼ 141% below peers (-46.7%)
vs Peers
vs Industry
Weak

REVB financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.9
▲ 56% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
-0.1
▼ 112% below peers (1.0)
vs Peers
vs Industry
More volatile

REVB fundamentals radar

REVB Peer median Industry

REVB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

REVB vs peers: key metrics

Latest News

No related news yet